Defence Therapeutics CEO outlines three strategic priorities in letter

Go back to Defence Therapeutics CEO outlines three strategic priorities in letter
(NYSE: DTC) Delayed: 19.55 --0 (-0%)
Previous Close $19.55    52 Week High $ 
Open $19.55    52 Week Low $ 
Day High $19.55    P/E N/A 
Day Low $19.55    EPS $ 
Volume 2,740,810       

(AMEX: DTCFF) Delayed: 0.28 --0 (-0%)
Previous Close $0.28    52 Week High $ 
Open $0.28    52 Week Low $ 
Day High $0.28    P/E N/A 
Day Low $0.28    EPS $ 
Volume 8,967